We are live on ! Find out more
HKIM

Hayek Kallen Investment Management Portfolio holdings

AUM $307M
1-Year Est. Return 18.5%
This Fund
S&P 500
This Quarter Est. Return
-1.49%
1 Year Est. Return
+18.5%
3 Year Est. Return
+68.46%
5 Year Est. Return
+97.89%
10 Year Est. Return
+297.02%
AUM
$134M
AUM Growth
-$1.79M
Cap. Flow
+$968K
Cap. Flow %
0.72%
Top 10 Hldgs %
39.09%
Holding
61
New
1
Increased
32
Reduced
14
Closed
10

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$1.18M
2
ABBV icon
AbbVie
ABBV
+$1.06M
3
NVIV
InVivo Therapeutics Holdings Corp
NVIV
+$264K
4
PFE icon
Pfizer
PFE
+$241K
5
T icon
AT&T
T
+$214K

Sector Composition

Rank Sector Weight
1 Healthcare 22.35%
2 Consumer Staples 19.45%
3 Technology 16.81%
4 Industrials 10.04%
5 Energy 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.15T
$6.82M 5.1%
50,136
+395
+0.8% +$56.3K
AAPL icon
2
Apple
AAPL
$4.46T
$5.55M 4.14%
176,908
+908
+0.5% +$29K
XOM icon
3
ExxonMobil
XOM
$651B
$5.42M 4.05%
65,106
+1,030
+2% +$88.6K
MSFT icon
4
Microsoft
MSFT
$3.75T
$5.36M 4%
121,388
+3,410
+3% +$156K
VZ icon
5
Verizon
VZ
$193B
$5.27M 3.94%
113,131
+1,054
+0.9% +$51.6K
NVS icon
6
Novartis
NVS
$297B
$5.19M 3.88%
58,894
-343
-0.6% -$31.5K
TMO icon
7
Thermo Fisher Scientific
TMO
$220B
$4.86M 3.63%
37,435
+105
+0.3% +$13.7K
CHL
8
DELISTED
China Mobile Limited
CHL
$4.78M 3.57%
74,636
-1,165
-2% -$79.6K
JNJ icon
9
Johnson & Johnson
JNJ
$627B
$4.63M 3.46%
47,521
+146
+0.3% +$14.6K
TEVA icon
10
Teva Pharmaceuticals
TEVA
$41.3B
$4.44M 3.32%
75,112
+681
+0.9% +$42K
GE icon
11
GE Aerospace
GE
$386B
$4.23M 3.16%
33,232
-877
-3% -$114K
INTC icon
12
Intel
INTC
$491B
$4.2M 3.13%
137,910
+2,895
+2% +$93.6K
KO icon
13
Coca-Cola
KO
$373B
$3.99M 2.98%
101,636
-421
-0.4% -$17.1K
PM icon
14
Philip Morris
PM
$291B
$3.7M 2.77%
46,186
-107
-0.2% -$8.8K
WMT icon
15
Walmart Inc
WMT
$887B
$3.7M 2.76%
156,426
+4,947
+3% +$126K
TAP icon
16
Molson Coors Class B
TAP
$7.83B
$3.66M 2.74%
52,480
+476
+0.9% +$35.4K
MO icon
17
Altria Group
MO
$112B
$3.5M 2.62%
71,627
-359
-0.5% -$18.2K
RTX icon
18
RTX Corp
RTX
$303B
$3.44M 2.57%
49,202
+1,360
+3% +$99.8K
WM icon
19
Waste Management
WM
$90.8B
$3.37M 2.52%
72,709
-420
-0.6% -$21.1K
NVO
20
Novo Nordisk
NVO
$207B
$3.22M 2.41%
117,680
+200
+0.2% +$5.62K
MCD icon
21
McDonald's
MCD
$196B
$3.04M 2.27%
31,941
-133
-0.4% -$12.9K
PEP icon
22
PepsiCo
PEP
$188B
$3.02M 2.26%
32,368
+948
+3% +$90.6K
PFE icon
23
Pfizer
PFE
$152B
$2.79M 2.09%
87,852
+7,386
+9% +$241K
ACN icon
24
Accenture
ACN
$108B
$2.76M 2.06%
28,498
-698
-2% -$66.7K
TGT icon
25
Target
TGT
$67.9B
$2.72M 2.03%
33,349
-593
-2% -$48K

Similar funds

Hayek Kallen Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Hayek Kallen Investment Management held 61 positions worth $134M, down 1.3% from $136M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Hayek Kallen Investment Management's Q2 2015 filing shows 1 new, 32 increased, 14 reduced and 10 closed positions. Its largest new stake was InVivo Therapeutics Holdings Corp: 1 share worth $177K. The largest sale was Dominion Energy, an estimated $552K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Staples and Technology.

  • Hayek Kallen Investment Management's largest Q2 2015 buy was InVivo Therapeutics Holdings Corp: 1 share worth $177K.
  • Hayek Kallen Investment Management added most to Union Pacific in Q2 2015, an estimated $1.18M increase.
  • Hayek Kallen Investment Management's biggest Q2 2015 reduction was GE Aerospace, cutting an estimated $114K.
  • Hayek Kallen Investment Management fully exited Dominion Energy in Q2 2015, selling an estimated $552K.
  • Hayek Kallen Investment Management's ten largest holdings make up 39% of its $134M portfolio in Q2 2015.
  • Hayek Kallen Investment Management opened 1 new position and closed 10 in Q2 2015.
  • Hayek Kallen Investment Management's portfolio value fell 1.3% quarter-over-quarter to $134M.

Based on Hayek Kallen Investment Management's 13F filing for Q2 2015, filed 13 Aug 2015.